Encyclopedic tumor analysis for guiding treatment of advanced, broadly refractory cancers: results from the RESILIENT trial

RESILIENT (CTRI/2018/02/011808) was a single arm, open label, phase II/III study to test if label agnostic therapy regimens guided by Encyclopedic Tumor Analysis (ETA) can offer meaningful clinical benefit for patients with relapsed refractory metastatic (r/r-m) malignancies. Patients with advanced...

Descripción completa

Detalles Bibliográficos
Autores principales: Nagarkar, Rajnish, Patil, Darshana, Crook, Timothy, Datta, Vineet, Bhalerao, Sagar, Dhande, Sonal, Palwe, Vijay, Roy, Shirsendu, Pandit, Prakash, Ghaisas, Ashwini, Page, Raymond, Kathuria, Harjeetsingh, Srinivasan, Ajay, Akolkar, Dadasaheb
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6771458/
https://www.ncbi.nlm.nih.gov/pubmed/31608137
http://dx.doi.org/10.18632/oncotarget.27188

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6771458/
https://www.ncbi.nlm.nih.gov/pubmed/31608137
http://dx.doi.org/10.18632/oncotarget.27188

Ejemplares similares